^
Association details:
Biomarker:No biomarker
Cancer:Childhood B Acute Lymphoblastic Leukemia
Drug:imatinib (Bcr-abl inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Pediatric Acute Lymphoblastic Leukemia: Other Recommended regimens…Imatinib